Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.
0.65EPS Dil.
1.70P/E
56.04MMarket Cap
Capital Structure
FRC
•
in mil. unless spec.
Jul'23
Oct'24
Jan'24
ST Debt
4
4
4
LT Borrowings
0
0
0
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
50
50
Market Capitalization
74
68
64
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
2.11
2.39
2.55
2.66
2.66
2.37
2.25
2.15
2.23
2.27
2.15
1.71
1.59
2.44
0.67
0.63
0.26
Revenue per ShareRevenue per Share
-0.29
-0.63
-0.59
-0.34
-1.01
-0.46
-0.23
-0.05
0.98
-0.05
-0.22
0.05
-0.60
0.16
-0.38
0.41
0.65
Basic EPS, GAAPBasic EPS, GAAP
-0.32
-0.38
-0.44
-0.25
-0.19
-0.28
-0.06
-0.12
1.12
-0.04
-0.10
-0.07
-0.41
-0.08
-0.41
-0.81
-0.92
Free Cash Flow per Basic ShareFree Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per ShareDividend per Share
-4.18
-4.65
-5.28
-5.56
-6.46
-6.70
-6.37
-6.17
-5.16
-5.19
-5.34
-5.24
-5.80
-5.57
-5.91
-5.36
-5.50
Book Value per ShareBook Value per Share
2.67
1.81
1.35
1.07
0.76
0.41
0.48
0.63
1.68
1.69
1.52
1.63
1.05
1.26
0.96
1.57
1.40
Tangible Book Value per ShareTangible Book Value per Share